Synthetic Biology and Synthetic Chemistry Join Forces

 

Article: Living GenoChemetics by hyphenating synthetic biology and synthetic chemistry in vivo

Authors: Sunil V. Sharma, Xiaoxue Tong, Cristina Pubill-Ulldemolins, Christopher Cartmell, Emma J. A. Bogosyan, Emma J. Rackham, Enrico Marelli, Refaat B. Hamed & Rebecca J. M. Goss

Journal: Nature Communications, August 2017

 

Synthetic chemistry reactions are usually kept far away from the selective environments that are required for cellular systems. Nevertheless, it is still possible to find common ground between the two by carefully balancing the requirements of each. As we have discussed previously, chemical reactions in biological systems are carried about by enzymes, which are bio-catalysts that have evolved over billions of years to catalyze many types of transformations. A major advantage of enzymatic chemistry is that enzymes can situate reactants into specific positions that result in highly selective products that traditional chemistry cannot generally accomplish. Still, there are many types of reactions that cellular systems and enzymes cannot yet carry out that traditional chemistry can. The authors aimed to expand this capacity by combining the best of both worlds from synthetic biology and synthetic chemistry. By combining ideas from these two fields into a strategy they call “GenoChemetics,” the authors manipulate both the genetic information and the chemical environment of an organism to produce novel compounds conveniently in living culture.

Before going into greater detail, here are some definitions to help along the way.

Synthetic Biology – The branch of science that combines biological principles with engineering applications. Essentially, synthetic biology aims to engineer biological systems to provide value for society.

Synthetic Chemistry – The combination of smaller chemical building blocks to produce complex chemical structures. Essentially, synthetic chemistry concerns the reactions of specific compounds to generate useful molecules.

To follow through with their goal, the authors needed to identify a chemical system that could provide acceptable yields at physiological conditions. The researchers solved this issue by screening a series of catalysts and ligands to discover ones that would provide reactivity at physiological temperature. From this screen, they determined that a palladium pre-catalyst of disodium 2-aminopyrimidine-4,6-diol would function well. This pre-catalyst is typically used for Suzuki-Mayuri cross-couplings, which are extremely important in organic chemistry due to their ability to generate carbon-carbon bonds in a wide variety of compounds. These reactions are catalyzed by palladium and require an activating group on each reactant, one of them typically a halogen, such as chlorine or bromine, and the other typically a boron or nitrogen group (Figure 1). Further optimization of the reaction conditions and reactant amounts then enabled this palladium-based cross-coupling reaction to be compatible with the organisms used, E. coli and S. coelicolor. 

 

Figure 1: An exemplary cross-coupling reaction with the pre-catalyst used in this article, 2-aminopyrimidine-4,6-diol. In this example, however, the catalyst is copper-based and the other activating group is a nitrogen, rather than boronic acid.

Next the authors needed a biological reactant that was suitable for a Pd-based cross-coupling reaction. Since microorganisms are known to produce a large variety of halogenated products, this was the route the authors took. Of these halogenated products, halogenated tryptophan is one of the most well-studied and many discovered enzymes are capable of adding a halogen group to various positions on the tryptophan scaffold. Specifically, in this work, the authors chose the enzyme PrnA, which is capable of adding a chlorine or bromine atom to tryptophan in the C7 position (Figure 2).

Figure 2: An overview of GenoChemetic reaction schemes. (A) The generation of bromo-tryptophan is first performed by E. coli expressing enzyme PrnA. Next, the cross-coupling reaction occurs to generate a chemically modified tryptophan. (B) This reaction is identical to reaction A except that the tryptophan molecule is attached to a larger peptide product, pacidamycin.

The authors first tested their designed system in E. coli that was engineered to express the halogenating enzyme, PrnA (Figure 2A). After showing that the production of 7-bromo-tryptophan and subsequent cross-coupling chemical modification were indeed possible in E. coli, the authors aimed to produce new-to-nature compounds, bromo-pacidamycin (3) and a novel pacidamycin derivative (3a). Pacidamycin on its own is a potent antibiotic small peptide that contains a tryptophan group. It has been reported many times previously that the addition of a halogen group increases a molecules bioactivity, which could make pacidamycin even more potent. By incorporating the gene cluster that produces pacidamycin and the 7-halo-tryptophan enzyme PrnA in conjuction with the cross-coupling reaction, the authors successfully produced compounds 3 and 3a in a living culture of S. coelicolor. 

The method developed herein combines the best of both worlds from synthetic biology and synthetic chemistry to generate complex molecules with greater diversity than what can typically be accomplished by either field. By tailoring mild synthetic chemistry methods to be compatible with living systems, these researchers have made artificial biochemical reactions a reality.

0 Shares

Leave a Reply